Sakae, M. 2024. Buprenorphine: Opioid Agonist-Antagonist for Refractory Pain of Sickle Cell Disease Patients During Hematopoietic Stem Cell Transplant, Uncontrolled By Full-Agonist Opioids. Journal of Opioid Management. 20, 4 (Sep. 2024), B14. DOI:https://doi.org/10.5055/bupe.24.rpj.1065.